Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q2 2024 Earnings

Apr 29Confirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
0
0.06
0.11
0.17

Details

Expected EPS
N/A
Actual EPS
0.1145055334108
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Shenzhen Hepalink Pharmaceutical Group.⁩ (⁦9989.HK⁩) has reported earnings of ⁦0.1145055334108⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts